Opinion: Magic Mushrooms Could Be the Next Investment Trend
Category: News & Politics
Via: krishna • 4 years ago • 2 commentsBy: By Editorial Dept
Disclaimer: Nothing in this seed is meant to be a recommendation to buy or sell any stock(s). Investing in stocks can result in the loss of all or part of your invested capital! (Heck, you might even end up being severely depressed!)
Related:
GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance
With the market surging back to life, investors are poised to pounce on the next trend...
And if you missed out on the cannabis boom then you’ll want to pay special attention to what’s coming next.
It has nothing to do with cannabis, THC or CBD…
Yet, this completely new market opportunity may be about to become front page news…
Because the FDA just “fast tracked” it.
Why? It could help solve a serious problem.
Big Pharma’s pills for mood disorders just don’t work for many people.
Currently, major anti-depressant medications only improve symptoms in 40 to 60 out of 100 people.
Plus, the side effects for some of these anti-depressants can be severe: insomnia, skin rashes, headaches, joint and muscle pain, stomach upset, nausea, or diarrhea. Such effects can be both temporary or chronic, depending on the patient.
According to the National Institute of Health, more than 16 million Americans suffered from depression in 2016, while 40 million suffer from anxiety, making it the single most common mental illness in the United States.
For certain groups, it’s much worse. About 30% of active-duty and military personnel deployed in Iraq and Afghanistan suffer from mental illness, particularly post-traumatic stress disorder (PTSD) and depression.
Traditional treatments just aren’t cutting it for some.